Comparative Evaluation of the Effects of Legacy and New Generation Perfluoralkyl Substances (PFAS) on Thyroid Cells
C6O4
PFOA
PFOS
endocrine disruptors
iodide
thyreocyte
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2022
2022
Historique:
received:
07
04
2022
accepted:
18
05
2022
entrez:
11
7
2022
pubmed:
12
7
2022
medline:
14
7
2022
Statut:
epublish
Résumé
Per- and poly-fluorinated alkyl substances (PFAS) are environment-persitent emerging endocrine disrupting chemicals raising health concerns worldwide. Exposure to PFAS has been associated with the imbalance of thyroid hormones. However, available studies addressing the cell mechanism underlying thyroid disrupting feature of legacy PFAS, such as perfluoro-octanoic acid (PFOA), perfluoro-octane-sulfonic acid (PFOS), and the new generation substitutes, such as C6O4, are still lacking. In this study the potential disrupting effect of PFOA, PFOS, and C6O4 on a murine thyroid cell model was assessed. A rat FRTL-5 cell line was used as the normal thyroid follicular cell model. Cell iodide-uptake, induced by thyroid stimulating hormone (TSH), was used to assess the functional impact of PFAS exposure on cell function. Tetrazolium salt-based cell viability assay and merocyanine 540-based cell staining were used to address the possible involvement of cell toxicity and membrane biophysical properties on altered cell function. The possible direct interaction of PFAS with TSH-receptor (TSH-R) was investigated by computer-based molecular docking and analysis of molecular dynamics. Evaluation of intracellular cAMP levels and gene expression analysis were used to validate the direct impairment of TSH-R-mediated downstream events upon PFAS exposure. Different from PFOS or C6O4, exposure to PFOA at a concentration ≥ 10 ng/mL was associated with significant impairment of the iodide uptake upon TSH stimulation (respectively: basal 100.0 ± 19.0%, CTRL + TSH 188.9 ± 7.8%, PFOA 10 ng/mL + TSH 120.4 ± 20.9%, p= 0.030 vs CTRL + TSH; PFOA 100 ng/mL + TSH 115,6 ± 12,3% p= 0.017 vs CTRL + TSH). No impairment of cell viability or membrane stability was observed. Computational analysis showed a possible direct differential interaction of C6O4, PFOA, and PFOS on a same binding site of the extracellular domain of TSH-R. Finally, exposure to PFOA was associated with a significant reduction of downstream intracellular cAMP levels and both sodium-iodide transporter and thyroperoxidase gene expression upon TSH-R stimulation. Our data suggest that legacy and new generation PFAS can differentially influence TSH dependent signaling pathways through the direct interaction with TSH-R.
Sections du résumé
Background
Per- and poly-fluorinated alkyl substances (PFAS) are environment-persitent emerging endocrine disrupting chemicals raising health concerns worldwide. Exposure to PFAS has been associated with the imbalance of thyroid hormones. However, available studies addressing the cell mechanism underlying thyroid disrupting feature of legacy PFAS, such as perfluoro-octanoic acid (PFOA), perfluoro-octane-sulfonic acid (PFOS), and the new generation substitutes, such as C6O4, are still lacking. In this study the potential disrupting effect of PFOA, PFOS, and C6O4 on a murine thyroid cell model was assessed.
Methods
A rat FRTL-5 cell line was used as the normal thyroid follicular cell model. Cell iodide-uptake, induced by thyroid stimulating hormone (TSH), was used to assess the functional impact of PFAS exposure on cell function. Tetrazolium salt-based cell viability assay and merocyanine 540-based cell staining were used to address the possible involvement of cell toxicity and membrane biophysical properties on altered cell function. The possible direct interaction of PFAS with TSH-receptor (TSH-R) was investigated by computer-based molecular docking and analysis of molecular dynamics. Evaluation of intracellular cAMP levels and gene expression analysis were used to validate the direct impairment of TSH-R-mediated downstream events upon PFAS exposure.
Results
Different from PFOS or C6O4, exposure to PFOA at a concentration ≥ 10 ng/mL was associated with significant impairment of the iodide uptake upon TSH stimulation (respectively: basal 100.0 ± 19.0%, CTRL + TSH 188.9 ± 7.8%, PFOA 10 ng/mL + TSH 120.4 ± 20.9%, p= 0.030 vs CTRL + TSH; PFOA 100 ng/mL + TSH 115,6 ± 12,3% p= 0.017 vs CTRL + TSH). No impairment of cell viability or membrane stability was observed. Computational analysis showed a possible direct differential interaction of C6O4, PFOA, and PFOS on a same binding site of the extracellular domain of TSH-R. Finally, exposure to PFOA was associated with a significant reduction of downstream intracellular cAMP levels and both sodium-iodide transporter and thyroperoxidase gene expression upon TSH-R stimulation.
Conclusions
Our data suggest that legacy and new generation PFAS can differentially influence TSH dependent signaling pathways through the direct interaction with TSH-R.
Identifiants
pubmed: 35813651
doi: 10.3389/fendo.2022.915096
pmc: PMC9259843
doi:
Substances chimiques
Fluorocarbons
0
Iodides
0
Thyrotropin
9002-71-5
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
915096Informations de copyright
Copyright © 2022 De Toni, Di Nisio, Rocca, Pedrucci, Garolla, Dall’Acqua, Guidolin, Ferlin and Foresta.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Environ Int. 2019 Jul;128:13-23
pubmed: 31029975
Thyroid. 2009 Dec;19(12):1407-12
pubmed: 20001722
Front Endocrinol (Lausanne). 2022 Jan 12;12:813785
pubmed: 35095772
Environ Int. 2021 Jul;152:106484
pubmed: 33740673
Int J Environ Res Public Health. 2015 May 29;12(6):6098-114
pubmed: 26035660
J Toxicol Sci. 2011 Aug;36(4):403-10
pubmed: 21804304
J Expo Sci Environ Epidemiol. 2019 Mar;29(2):131-147
pubmed: 30470793
Environ Sci Technol. 2018 Aug 21;52(16):9412-9418
pubmed: 30052437
J Clin Endocrinol Metab. 2013 Sep;98(9):E1456-64
pubmed: 23864701
Thyroid. 2006 Dec;16(12):1195-206
pubmed: 17199429
Environ Res. 2013 Oct;126:51-9
pubmed: 24053974
Toxics. 2021 Aug 19;9(8):
pubmed: 34437509
J Biol Chem. 1987 Feb 5;262(4):1575-82
pubmed: 3027094
J Endocrinol Invest. 2021 Aug;44(8):1625-1635
pubmed: 33315184
Endocr J. 2021 Jun 28;68(6):691-699
pubmed: 33583874
Endocr J. 2019 Apr 25;66(4):349-357
pubmed: 30814441
Thyroid. 2020 Nov;30(11):1556-1565
pubmed: 32368952
Hum Genomics. 2011 Jul;5(5):497-505
pubmed: 21807604
Environ Sci Pollut Res Int. 2015 Feb;22(3):2287-94
pubmed: 25182428
Int J Androl. 2008 Apr;31(2):161-9
pubmed: 18315716
Environ Sci Technol. 2002 Apr 1;36(7):146A-152A
pubmed: 11999053
Nat Rev Cardiol. 2017 Jan;14(1):39-55
pubmed: 27811932
Environ Pollut. 2018 Nov;242(Pt A):894-904
pubmed: 30373035
J Mol Endocrinol. 2011 Feb 15;46(2):81-99
pubmed: 21247981
Environ Int. 2022 Jan;158:106982
pubmed: 34781208
Environ Int. 2021 Sep;154:106584
pubmed: 33895438
Mol Reprod Dev. 2006 Dec;73(12):1591-9
pubmed: 16897700
Mol Endocrinol. 1993 Aug;7(8):1009-20
pubmed: 7901757
Eur J Med Chem. 2013 Jan;59:218-26
pubmed: 23229057
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Ann Pediatr Endocrinol Metab. 2017 Mar;22(1):6-14
pubmed: 28443254
Mol Cell Endocrinol. 2020 Sep 15;515:110922
pubmed: 32621861
Environ Pollut. 2018 Apr;235:974-982
pubmed: 29751401
Environ Int. 2012 Sep 15;45:78-85
pubmed: 22580293
Environ Health Perspect. 2009 Sep;117(9):1380-6
pubmed: 19750101
Int J Mol Sci. 2020 Jan 08;21(2):
pubmed: 31936344
Environ Res. 2021 Mar;194:110647
pubmed: 33358873
Environ Health Perspect. 2012 Jul;120(7):1036-41
pubmed: 22453676
J Endocrinol Invest. 2019 Nov;42(11):1329-1335
pubmed: 31102255
Environ Int. 2015 Feb;75:206-14
pubmed: 25483837
J Endocrinol Invest. 2020 May;43(5):641-652
pubmed: 31776969
Front Endocrinol (Lausanne). 2018 Apr 30;9:204
pubmed: 29760680
Environ Res. 2022 Jan;203:111794
pubmed: 34358507
PLoS One. 2018 May 10;13(5):e0197244
pubmed: 29746532
Biol Reprod. 2001 Aug;65(2):462-70
pubmed: 11466214
Science. 2022 Feb 18;375(6582):eabe8244
pubmed: 35175820
PLoS One. 2014 Sep 24;9(9):e107936
pubmed: 25251397
J Thyroid Res. 2012;2012:351864
pubmed: 23365787
Toxicol In Vitro. 2019 Jun;57:39-47
pubmed: 30738889
Nucleic Acids Res. 2018 Jul 2;46(W1):W338-W343
pubmed: 29762700